Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ludwig

Showing results (431-440 of 500) with videos related to

Pageof 50
Sort By:
Leukemia|January 27, 2006
Near-tetraploid acute myeloid leukemias: an EGIL retrospective study of 25 casesM-C Béné, G Castoldi, A Derolf, et al.
Scientific Reports|July 16, 2025
Laser based 100 GeV electron acceleration scheme for muon productionJ D Ludwig, S C Wilks, A J Kemp, et al.
Klinische Padiatrie|May 24, 2013
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000M Schrappe, A Möricke, A Reiter, et al.
Biology of Reproduction|August 26, 2022
Ferumoxytol dynamic contrast enhanced magnetic resonance imaging identifies altered placental cotyledon perfusion in rhesus macaques†Daniel P Seiter, Sydney M Nguyen, Terry K Morgan, et al.
Leukemia|September 11, 2009
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCGE Lengfelder, C Haferlach, S Saussele, et al.
Leukemia|August 15, 2000
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative GroupE Lengfelder, A Reichert, C Schoch, et al.
Oncogene|June 22, 2010
Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastomaX Shang, S A Vasudevan, Y Yu, et al.
International Journal of Hematology|February 24, 2001
Acute myeloid leukemia in adults: is postconsolidation maintenance therapy necessary?T Büchner, W Hiddemann, B Wörmann, et al.
Annals of Hematology|May 6, 2004
Subgroup specific therapy effects in AML: AMLCG dataTh Büchner, W Hiddemann, W E Berdel, et al.
Leukemia & Lymphoma|July 28, 2016
Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this DistinctionM Engelhard, G Brittinger, R Heinz, et al.
Pageof 50

Showing results (431-440 of 500) with videos related to

Sort By:
Pageof 50
Leukemia|January 27, 2006
Near-tetraploid acute myeloid leukemias: an EGIL retrospective study of 25 casesM-C Béné, G Castoldi, A Derolf, et al.
Scientific Reports|July 16, 2025
Laser based 100 GeV electron acceleration scheme for muon productionJ D Ludwig, S C Wilks, A J Kemp, et al.
Klinische Padiatrie|May 24, 2013
Key treatment questions in childhood acute lymphoblastic leukemia: results in 5 consecutive trials performed by the ALL-BFM study group from 1981 to 2000M Schrappe, A Möricke, A Reiter, et al.
Biology of Reproduction|August 26, 2022
Ferumoxytol dynamic contrast enhanced magnetic resonance imaging identifies altered placental cotyledon perfusion in rhesus macaques†Daniel P Seiter, Sydney M Nguyen, Terry K Morgan, et al.
Leukemia|September 11, 2009
High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCGE Lengfelder, C Haferlach, S Saussele, et al.
Leukemia|August 15, 2000
Double induction strategy including high dose cytarabine in combination with all-trans retinoic acid: effects in patients with newly diagnosed acute promyelocytic leukemia. German AML Cooperative GroupE Lengfelder, A Reichert, C Schoch, et al.
Oncogene|June 22, 2010
Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastomaX Shang, S A Vasudevan, Y Yu, et al.
International Journal of Hematology|February 24, 2001
Acute myeloid leukemia in adults: is postconsolidation maintenance therapy necessary?T Büchner, W Hiddemann, B Wörmann, et al.
Annals of Hematology|May 6, 2004
Subgroup specific therapy effects in AML: AMLCG dataTh Büchner, W Hiddemann, W E Berdel, et al.
Leukemia & Lymphoma|July 28, 2016
Chronic Lymphocytic Leukemia (B-CLL) and Immunocytoma (LP-IC): Clinical and Prognostic Relevance of this DistinctionM Engelhard, G Brittinger, R Heinz, et al.
Pageof 50